img

Global Norovirus Vaccine Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Norovirus Vaccine Market Insights, Forecast to 2034

Global Norovirus Vaccine market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Norovirus Vaccine industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Norovirus, a human caliciviridae virus, is mainly transmitted through the fecal-oral route and is highly contagious. It has no obvious pathogenicity in healthy people, but can cause serious illness and complications in immunocompromised patients, the elderly and children. It can last for a long time, and the main symptoms of infection are diarrhea and vomiting. Norovirus vaccines can effectively prevent viral infections, but the current existing vaccines fail to meet clinical needs, resulting in a large demand gap. As people's health awareness increases, there will be a huge demand for norovirus vaccines in the future.
Report Covers
This report presents an overview of global Norovirus Vaccine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Norovirus Vaccine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Hillevax
Vaxart
Moderna
UMN Pharma
Daiichi Sankyo
Kanghua Biology
Beijing Institute of Biological Products
Zhifei Bio
China Biotechnology Co., Ltd.
North China Pharmaceutical
Segment by Type
Bivalent
Quadrivalent
Hexavalent

Segment by Application


Hospital
Clinic
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Norovirus Vaccine plant distribution, commercial date of Norovirus Vaccine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Norovirus Vaccine introduction, etc. Norovirus Vaccine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Norovirus Vaccine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Norovirus Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Norovirus Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Bivalent
1.2.3 Quadrivalent
1.2.4 Hexavalent
1.3 Market by Application
1.3.1 Global Norovirus Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Norovirus Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Norovirus Vaccine Revenue by Region
2.2.1 Global Norovirus Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Norovirus Vaccine Revenue by Region (2018-2024)
2.2.3 Global Norovirus Vaccine Revenue by Region (2024-2029)
2.2.4 Global Norovirus Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Norovirus Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Norovirus Vaccine Sales by Region
2.4.1 Global Norovirus Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Norovirus Vaccine Sales by Region (2018-2024)
2.4.3 Global Norovirus Vaccine Sales by Region (2024-2029)
2.4.4 Global Norovirus Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Norovirus Vaccine Sales by Manufacturers
3.1.1 Global Norovirus Vaccine Sales by Manufacturers (2018-2024)
3.1.2 Global Norovirus Vaccine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Norovirus Vaccine in 2022
3.2 Global Norovirus Vaccine Revenue by Manufacturers
3.2.1 Global Norovirus Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Norovirus Vaccine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Norovirus Vaccine Revenue in 2022
3.3 Global Key Players of Norovirus Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Norovirus Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Norovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Norovirus Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Norovirus Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Norovirus Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Norovirus Vaccine Sales by Type
4.1.1 Global Norovirus Vaccine Historical Sales by Type (2018-2024)
4.1.2 Global Norovirus Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Norovirus Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Norovirus Vaccine Revenue by Type
4.2.1 Global Norovirus Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Norovirus Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Norovirus Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Norovirus Vaccine Price by Type
4.3.1 Global Norovirus Vaccine Price by Type (2018-2024)
4.3.2 Global Norovirus Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Norovirus Vaccine Sales by Application
5.1.1 Global Norovirus Vaccine Historical Sales by Application (2018-2024)
5.1.2 Global Norovirus Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Norovirus Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Norovirus Vaccine Revenue by Application
5.2.1 Global Norovirus Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Norovirus Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Norovirus Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Norovirus Vaccine Price by Application
5.3.1 Global Norovirus Vaccine Price by Application (2018-2024)
5.3.2 Global Norovirus Vaccine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Norovirus Vaccine Market Size by Type
6.1.1 US & Canada Norovirus Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Norovirus Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Norovirus Vaccine Market Size by Application
6.2.1 US & Canada Norovirus Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Norovirus Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Norovirus Vaccine Market Size by Country
6.3.1 US & Canada Norovirus Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Norovirus Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Norovirus Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Norovirus Vaccine Market Size by Type
7.1.1 Europe Norovirus Vaccine Sales by Type (2018-2029)
7.1.2 Europe Norovirus Vaccine Revenue by Type (2018-2029)
7.2 Europe Norovirus Vaccine Market Size by Application
7.2.1 Europe Norovirus Vaccine Sales by Application (2018-2029)
7.2.2 Europe Norovirus Vaccine Revenue by Application (2018-2029)
7.3 Europe Norovirus Vaccine Market Size by Country
7.3.1 Europe Norovirus Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Norovirus Vaccine Sales by Country (2018-2029)
7.3.3 Europe Norovirus Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Norovirus Vaccine Market Size
8.1.1 China Norovirus Vaccine Sales (2018-2029)
8.1.2 China Norovirus Vaccine Revenue (2018-2029)
8.2 China Norovirus Vaccine Market Size by Application
8.2.1 China Norovirus Vaccine Sales by Application (2018-2029)
8.2.2 China Norovirus Vaccine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Norovirus Vaccine Market Size by Type
9.1.1 Asia Norovirus Vaccine Sales by Type (2018-2029)
9.1.2 Asia Norovirus Vaccine Revenue by Type (2018-2029)
9.2 Asia Norovirus Vaccine Market Size by Application
9.2.1 Asia Norovirus Vaccine Sales by Application (2018-2029)
9.2.2 Asia Norovirus Vaccine Revenue by Application (2018-2029)
9.3 Asia Norovirus Vaccine Sales by Region
9.3.1 Asia Norovirus Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Norovirus Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Norovirus Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Norovirus Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Norovirus Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Norovirus Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Norovirus Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Norovirus Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Norovirus Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Norovirus Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Norovirus Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Norovirus Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Norovirus Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Hillevax
11.1.1 Hillevax Company Information
11.1.2 Hillevax Overview
11.1.3 Hillevax Norovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Hillevax Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Hillevax Recent Developments
11.2 Vaxart
11.2.1 Vaxart Company Information
11.2.2 Vaxart Overview
11.2.3 Vaxart Norovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Vaxart Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Vaxart Recent Developments
11.3 Moderna
11.3.1 Moderna Company Information
11.3.2 Moderna Overview
11.3.3 Moderna Norovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Moderna Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Moderna Recent Developments
11.4 UMN Pharma
11.4.1 UMN Pharma Company Information
11.4.2 UMN Pharma Overview
11.4.3 UMN Pharma Norovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 UMN Pharma Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 UMN Pharma Recent Developments
11.5 Daiichi Sankyo
11.5.1 Daiichi Sankyo Company Information
11.5.2 Daiichi Sankyo Overview
11.5.3 Daiichi Sankyo Norovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Daiichi Sankyo Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Daiichi Sankyo Recent Developments
11.6 Kanghua Biology
11.6.1 Kanghua Biology Company Information
11.6.2 Kanghua Biology Overview
11.6.3 Kanghua Biology Norovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Kanghua Biology Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Kanghua Biology Recent Developments
11.7 Beijing Institute of Biological Products
11.7.1 Beijing Institute of Biological Products Company Information
11.7.2 Beijing Institute of Biological Products Overview
11.7.3 Beijing Institute of Biological Products Norovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Beijing Institute of Biological Products Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Beijing Institute of Biological Products Recent Developments
11.8 Zhifei Bio
11.8.1 Zhifei Bio Company Information
11.8.2 Zhifei Bio Overview
11.8.3 Zhifei Bio Norovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Zhifei Bio Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Zhifei Bio Recent Developments
11.9 China Biotechnology Co., Ltd.
11.9.1 China Biotechnology Co., Ltd. Company Information
11.9.2 China Biotechnology Co., Ltd. Overview
11.9.3 China Biotechnology Co., Ltd. Norovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 China Biotechnology Co., Ltd. Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 China Biotechnology Co., Ltd. Recent Developments
11.10 North China Pharmaceutical
11.10.1 North China Pharmaceutical Company Information
11.10.2 North China Pharmaceutical Overview
11.10.3 North China Pharmaceutical Norovirus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 North China Pharmaceutical Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 North China Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Norovirus Vaccine Industry Chain Analysis
12.2 Norovirus Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Norovirus Vaccine Production Mode & Process
12.4 Norovirus Vaccine Sales and Marketing
12.4.1 Norovirus Vaccine Sales Channels
12.4.2 Norovirus Vaccine Distributors
12.5 Norovirus Vaccine Customers
13 Market Dynamics
13.1 Norovirus Vaccine Industry Trends
13.2 Norovirus Vaccine Market Drivers
13.3 Norovirus Vaccine Market Challenges
13.4 Norovirus Vaccine Market Restraints
14 Key Findings in The Global Norovirus Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Norovirus Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Bivalent
Table 3. Major Manufacturers of Quadrivalent
Table 4. Major Manufacturers of Hexavalent
Table 5. Global Norovirus Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Norovirus Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Norovirus Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Norovirus Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Norovirus Vaccine Revenue Market Share by Region (2018-2024)
Table 10. Global Norovirus Vaccine Revenue Market Share by Region (2024-2029)
Table 11. Global Norovirus Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Norovirus Vaccine Sales by Region (2018-2024) & (K Units)
Table 13. Global Norovirus Vaccine Sales by Region (2024-2029) & (K Units)
Table 14. Global Norovirus Vaccine Sales Market Share by Region (2018-2024)
Table 15. Global Norovirus Vaccine Sales Market Share by Region (2024-2029)
Table 16. Global Norovirus Vaccine Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global Norovirus Vaccine Sales Share by Manufacturers (2018-2024)
Table 18. Global Norovirus Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Norovirus Vaccine Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Norovirus Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Norovirus Vaccine Price by Manufacturers 2018-2024 (US$/Unit)
Table 22. Global Norovirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Norovirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Norovirus Vaccine as of 2022)
Table 24. Global Key Manufacturers of Norovirus Vaccine, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Norovirus Vaccine, Product Offered and Application
Table 26. Global Key Manufacturers of Norovirus Vaccine, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Norovirus Vaccine Sales by Type (2018-2024) & (K Units)
Table 29. Global Norovirus Vaccine Sales by Type (2024-2029) & (K Units)
Table 30. Global Norovirus Vaccine Sales Share by Type (2018-2024)
Table 31. Global Norovirus Vaccine Sales Share by Type (2024-2029)
Table 32. Global Norovirus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Norovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Norovirus Vaccine Revenue Share by Type (2018-2024)
Table 35. Global Norovirus Vaccine Revenue Share by Type (2024-2029)
Table 36. Norovirus Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 37. Global Norovirus Vaccine Price Forecast by Type (2024-2029) & (US$/Unit)
Table 38. Global Norovirus Vaccine Sales by Application (2018-2024) & (K Units)
Table 39. Global Norovirus Vaccine Sales by Application (2024-2029) & (K Units)
Table 40. Global Norovirus Vaccine Sales Share by Application (2018-2024)
Table 41. Global Norovirus Vaccine Sales Share by Application (2024-2029)
Table 42. Global Norovirus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Norovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Norovirus Vaccine Revenue Share by Application (2018-2024)
Table 45. Global Norovirus Vaccine Revenue Share by Application (2024-2029)
Table 46. Norovirus Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 47. Global Norovirus Vaccine Price Forecast by Application (2024-2029) & (US$/Unit)
Table 48. US & Canada Norovirus Vaccine Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada Norovirus Vaccine Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Norovirus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Norovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Norovirus Vaccine Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada Norovirus Vaccine Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Norovirus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Norovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Norovirus Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Norovirus Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Norovirus Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Norovirus Vaccine Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada Norovirus Vaccine Sales by Country (2024-2029) & (K Units)
Table 61. Europe Norovirus Vaccine Sales by Type (2018-2024) & (K Units)
Table 62. Europe Norovirus Vaccine Sales by Type (2024-2029) & (K Units)
Table 63. Europe Norovirus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Norovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Norovirus Vaccine Sales by Application (2018-2024) & (K Units)
Table 66. Europe Norovirus Vaccine Sales by Application (2024-2029) & (K Units)
Table 67. Europe Norovirus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Norovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Norovirus Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Norovirus Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Norovirus Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Norovirus Vaccine Sales by Country (2018-2024) & (K Units)
Table 73. Europe Norovirus Vaccine Sales by Country (2024-2029) & (K Units)
Table 74. China Norovirus Vaccine Sales by Type (2018-2024) & (K Units)
Table 75. China Norovirus Vaccine Sales by Type (2024-2029) & (K Units)
Table 76. China Norovirus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Norovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Norovirus Vaccine Sales by Application (2018-2024) & (K Units)
Table 79. China Norovirus Vaccine Sales by Application (2024-2029) & (K Units)
Table 80. China Norovirus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Norovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Norovirus Vaccine Sales by Type (2018-2024) & (K Units)
Table 83. Asia Norovirus Vaccine Sales by Type (2024-2029) & (K Units)
Table 84. Asia Norovirus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Norovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Norovirus Vaccine Sales by Application (2018-2024) & (K Units)
Table 87. Asia Norovirus Vaccine Sales by Application (2024-2029) & (K Units)
Table 88. Asia Norovirus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Norovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Norovirus Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Norovirus Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Norovirus Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Norovirus Vaccine Sales by Region (2018-2024) & (K Units)
Table 94. Asia Norovirus Vaccine Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Norovirus Vaccine Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Norovirus Vaccine Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Norovirus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Norovirus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Norovirus Vaccine Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Norovirus Vaccine Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Norovirus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Norovirus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Norovirus Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Norovirus Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Norovirus Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Norovirus Vaccine Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Norovirus Vaccine Sales by Country (2024-2029) & (K Units)
Table 108. Hillevax Company Information
Table 109. Hillevax Description and Major Businesses
Table 110. Hillevax Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Hillevax Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Hillevax Recent Developments
Table 113. Vaxart Company Information
Table 114. Vaxart Description and Major Businesses
Table 115. Vaxart Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Vaxart Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Vaxart Recent Developments
Table 118. Moderna Company Information
Table 119. Moderna Description and Major Businesses
Table 120. Moderna Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Moderna Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Moderna Recent Developments
Table 123. UMN Pharma Company Information
Table 124. UMN Pharma Description and Major Businesses
Table 125. UMN Pharma Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. UMN Pharma Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. UMN Pharma Recent Developments
Table 128. Daiichi Sankyo Company Information
Table 129. Daiichi Sankyo Description and Major Businesses
Table 130. Daiichi Sankyo Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. Daiichi Sankyo Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Daiichi Sankyo Recent Developments
Table 133. Kanghua Biology Company Information
Table 134. Kanghua Biology Description and Major Businesses
Table 135. Kanghua Biology Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. Kanghua Biology Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Kanghua Biology Recent Developments
Table 138. Beijing Institute of Biological Products Company Information
Table 139. Beijing Institute of Biological Products Description and Major Businesses
Table 140. Beijing Institute of Biological Products Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. Beijing Institute of Biological Products Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Beijing Institute of Biological Products Recent Developments
Table 143. Zhifei Bio Company Information
Table 144. Zhifei Bio Description and Major Businesses
Table 145. Zhifei Bio Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. Zhifei Bio Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Zhifei Bio Recent Developments
Table 148. China Biotechnology Co., Ltd. Company Information
Table 149. China Biotechnology Co., Ltd. Description and Major Businesses
Table 150. China Biotechnology Co., Ltd. Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. China Biotechnology Co., Ltd. Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. China Biotechnology Co., Ltd. Recent Developments
Table 153. North China Pharmaceutical Company Information
Table 154. North China Pharmaceutical Description and Major Businesses
Table 155. North China Pharmaceutical Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. North China Pharmaceutical Norovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. North China Pharmaceutical Recent Developments
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. Norovirus Vaccine Distributors List
Table 161. Norovirus Vaccine Customers List
Table 162. Norovirus Vaccine Market Trends
Table 163. Norovirus Vaccine Market Drivers
Table 164. Norovirus Vaccine Market Challenges
Table 165. Norovirus Vaccine Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Norovirus Vaccine Product Picture
Figure 2. Global Norovirus Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Norovirus Vaccine Market Share by Type in 2022 & 2029
Figure 4. Bivalent Product Picture
Figure 5. Quadrivalent Product Picture
Figure 6. Hexavalent Product Picture
Figure 7. Global Norovirus Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Norovirus Vaccine Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Norovirus Vaccine Report Years Considered
Figure 13. Global Norovirus Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Norovirus Vaccine Revenue 2018-2029 (US$ Million)
Figure 15. Global Norovirus Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Norovirus Vaccine Revenue Market Share by Region (2018-2029)
Figure 17. Global Norovirus Vaccine Sales 2018-2029 ((K Units)
Figure 18. Global Norovirus Vaccine Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Norovirus Vaccine Sales YoY (2018-2029) & (K Units)
Figure 20. US & Canada Norovirus Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Norovirus Vaccine Sales YoY (2018-2029) & (K Units)
Figure 22. Europe Norovirus Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Norovirus Vaccine Sales YoY (2018-2029) & (K Units)
Figure 24. China Norovirus Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Norovirus Vaccine Sales YoY (2018-2029) & (K Units)
Figure 26. Asia (excluding China) Norovirus Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Norovirus Vaccine Sales YoY (2018-2029) & (K Units)
Figure 28. Middle East, Africa and Latin America Norovirus Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Norovirus Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Norovirus Vaccine in the World: Market Share by Norovirus Vaccine Revenue in 2022
Figure 31. Global Norovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Norovirus Vaccine Sales Market Share by Type (2018-2029)
Figure 33. Global Norovirus Vaccine Revenue Market Share by Type (2018-2029)
Figure 34. Global Norovirus Vaccine Sales Market Share by Application (2018-2029)
Figure 35. Global Norovirus Vaccine Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Norovirus Vaccine Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Norovirus Vaccine Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Norovirus Vaccine Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Norovirus Vaccine Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Norovirus Vaccine Revenue Share by Country (2018-2029)
Figure 41. US & Canada Norovirus Vaccine Sales Share by Country (2018-2029)
Figure 42. U.S. Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Norovirus Vaccine Sales Market Share by Type (2018-2029)
Figure 45. Europe Norovirus Vaccine Revenue Market Share by Type (2018-2029)
Figure 46. Europe Norovirus Vaccine Sales Market Share by Application (2018-2029)
Figure 47. Europe Norovirus Vaccine Revenue Market Share by Application (2018-2029)
Figure 48. Europe Norovirus Vaccine Revenue Share by Country (2018-2029)
Figure 49. Europe Norovirus Vaccine Sales Share by Country (2018-2029)
Figure 50. Germany Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 51. France Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 55. China Norovirus Vaccine Sales Market Share by Type (2018-2029)
Figure 56. China Norovirus Vaccine Revenue Market Share by Type (2018-2029)
Figure 57. China Norovirus Vaccine Sales Market Share by Application (2018-2029)
Figure 58. China Norovirus Vaccine Revenue Market Share by Application (2018-2029)
Figure 59. Asia Norovirus Vaccine Sales Market Share by Type (2018-2029)
Figure 60. Asia Norovirus Vaccine Revenue Market Share by Type (2018-2029)
Figure 61. Asia Norovirus Vaccine Sales Market Share by Application (2018-2029)
Figure 62. Asia Norovirus Vaccine Revenue Market Share by Application (2018-2029)
Figure 63. Asia Norovirus Vaccine Revenue Share by Region (2018-2029)
Figure 64. Asia Norovirus Vaccine Sales Share by Region (2018-2029)
Figure 65. Japan Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 69. India Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Norovirus Vaccine Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Norovirus Vaccine Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Norovirus Vaccine Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Norovirus Vaccine Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Norovirus Vaccine Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Norovirus Vaccine Sales Share by Country (2018-2029)
Figure 76. Brazil Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Norovirus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 81. Norovirus Vaccine Value Chain
Figure 82. Norovirus Vaccine Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries